A comprehensive phenotypic and genotypic taxonomic review of Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae): a novel agent of cutaneous (non-ulcerated) and visceral leishmaniasis in Honduras, Central America
Tropical Diseases, Travel Medicine and Vaccines · Published 2025-07-27 · DOI 10.1186/s40794-025-00264-1
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1186/s40794-025-00264-1
Abstract
Abstract Non-ulcerated cutaneous leishmaniasis (NUCL) is an atypical clinical form of leishmaniasis first described, in 1988, by Ponce and collaborators, in Honduras, Central America, characterized by isolated or disseminated closed skin lesions appearing as papules, nodules, or infiltrated plaques, primarily in adolescents and young adults. Leishmania (L.) chagasi was then identified as the causal agent of both NUCL and American visceral leishmaniasis (AVL) in Honduras, though NUCL has been reported as more prevalent. However, due to the uncertain taxonomic classification of the NUCL-causing parasite, especially since L. (L.) chagasi has not been associated to this form of the disease in South America, this study conducted a comprehensive taxonomic review incorporating phenotypic (biological and clinical-immunopathological) and genotypic (genomic/molecular) analyses. Biologically, Honduran parasite-LPG does not have Gal (β1,4) Man (α1)-PO4 side chains common to all Leishmania LPGs. From a clinical-pathogenic perspective, NUCL is unique, it does not ulcerate like cutaneous leishmaniasis due to L. (L.) chagasi or L. (L.) infantum. Molecular findings showed that the Honduran parasite is more ancestral than all known viscerotropic Leishmania species, exhibited an unprecedented structural variation on chromosome 17 with the highest frequency of genomic SNPs, formed a distinct phylogenetic lineage, and displayed a homozygous SNP profile typical of a parental (non-hybrid) parasite. Building on these findings, a new species, Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae), is proposed in honor of Professor Carlos Ponce, who first described NUCL in Honduras. This study formally classifies L. (L.) poncei n. sp. as a novel Leishmania species responsible for both NUCL and AVL in Honduras, Central America.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- Detection of Leishmania infantum DNA in Sand Flies and Assessment of Zoonotic Transmission Risk in Central Honduras: A One Health Approach · Tropical Medicine and Infectious Disease · 2026 · Cites or is cited by this article
- Polymorphism of the dihydropteroate synthase resistance gene of Plasmodium falciparum in three hospitals in Mbouda, Western Cameroon · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- The global outbreak of Oropouche virus: surveillance of global trends · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Rwanda’s National Reference Laboratory Operational Capacity during the 2024 Marburg Virus Disease Outbreak Response · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Self-reported hepatitis B vaccination uptake and associated factors among adults in a tertiary hospital, Nasarawa State, Nigeria · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Clinical, laboratory features and treatment outcomes of patients infected with Fasciola in Northern Vietnam, 2019–2023 · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- The silent microbial shift: climate change amplifies pathogen evolution, microbiome dysbiosis, and antimicrobial resistance · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Safety of COVID-19 revaccination in patients with prior hypersensitivity reactions: a retrospective study · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Furuncular cutaneous myiasis after travel in South America: case report and epidemiologic, diagnostic and management considerations · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Integrated strategies for controlling and eliminating Neglected Tropical Diseases in Sub-Saharan Africa: a review of approaches, challenges, and opportunities · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal